Atopic dermatitis (AD) negatively impacts patients' mental health (MH), especially when a patient has severe AD, according to a study published online March 14 in Dermatitis.
Apr 23, 2024
0
10
A drug that can help prevent migraines could soon be available on the NHS. Atogepant (brand name: Aquipta) was recently recommended by the National Institute for Health and Care Excellence (NICE) to prevent episodic and chronic ...
Apr 23, 2024
0
3
Repeated exposure to explosive blasts has the potential to cause brain injuries, but there is currently no diagnostic test for these injuries. In a study of 30 active-duty United States SOF personnel, researchers found that ...
Apr 22, 2024
0
49
Metachromatic leukodystrophy is a rare genetic disorder that mainly affects young children and results in severe neurological symptoms accompanied by a loss of motor and intellectual capacities. At Paris Brain Institute, ...
Apr 22, 2024
0
8
New Swinburne-led research has revealed that a third of people with irritable bowel syndrome (IBS) may suffer from symptoms of disordered eating and orthorexia—an obsession with healthy eating.
Apr 22, 2024
0
0
Irritable bowel syndrome (IBS) can significantly disrupt a person's daily life. Some people suffer in silence because of painful stomach cramps, diarrhea, and constipation. These symptoms can significantly affect a person's ...
Apr 19, 2024
0
2
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has found that the effectiveness of ADHD medication may be associated with an individual's neuroanatomy.
Apr 18, 2024
0
127
Tulane University researchers have identified a promising new approach to treating persistent neurological symptoms associated with Lyme disease, offering hope to patients who suffer from long-term effects of the bacterial ...
Apr 18, 2024
0
0
Pink eye is extremely common in kids. According to the Centers for Disease Control and Prevention, public schoolchildren in the U.S. miss 3 million school days each year because of pink eye.
Apr 18, 2024
0
0
Prasinezumab, a monoclonal antibody, is shown to reduce signs of motor deterioration in individuals with Parkinson's disease (PD) who have rapidly progressing disease, as reported in an exploratory analysis of data from a ...
Apr 16, 2024
0
111
